Heterogeneity of breast cancer: etiology and clinical relevance.
about
Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cellsNext generation sequencing applications for breast cancer research.Toward precision medicine of breast cancerMammary gland stem cells and their application in breast cancerAKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung CancerMeta-analysis of Aurora Kinase A (AURKA) Expression Data Reveals a Significant Correlation Between Increased AURKA Expression and Distant Metastases in Human ER-positive Breast Cancers.A murine preclinical syngeneic transplantation model for breast cancer precision medicine.Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.Epigenetic and metabolic regulation of breast cancer stem cells.Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.May CTC technologies promote better cancer management?Comparison of methods for the isolation of human breast epithelial and myoepithelial cells.Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response.Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjectsPrognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancerNext generation sequencing in cancer research and clinical applicationKeeping an open mind: highlights and controversies of the breast cancer stem cell theoryIdentification of breast cancer mechanism based on weighted gene coexpression network analysis.Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA.Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.Association between Dietary Inflammatory Index (DII) and Risk of Breast Cancer: a Case-Control Study
P2860
Q21090900-5138064D-38A1-45FA-8AD9-2B0E83ECC9DEQ27690994-7D74630C-1A87-4BF2-8920-8EC06E4CED62Q28073967-44211CD8-F9FF-4B3F-BF55-CF2BBED932DEQ28075791-2BBAE669-6FD6-4FCA-AFF6-7BC070294A5FQ28550038-6AD79620-371E-4C5D-B2DF-3266FE83C24CQ30800052-D8125AA0-6C38-4952-9B3F-F4D44082340EQ33580224-61016255-822A-46AD-B48B-5BA58B37E073Q33717428-CDCA1666-951E-4CDF-8C7C-907F531C246AQ33899089-3DA0FD5B-95AF-458A-8790-1163EE433557Q34815370-140760E5-6348-4217-A688-C3B49A53617BQ34890549-9A00CC05-FCD7-4ABD-B9AD-A32EF40B132AQ34994693-69CB8DCA-A8E5-4EE0-8625-A8DA74B6B5B1Q35016353-CA85735E-5C1C-41DB-AEEA-F699BBD29338Q35633230-4C470E0C-FE2A-482E-9A13-3DA35C0DE902Q35804283-8D11D5C0-5750-46CD-831B-A1A9D7D7EDD3Q35878669-5C591513-C35C-41D2-B3C2-6384AD4A0A14Q36041569-EBEB5BAE-23CF-432F-BC52-A6BCBAF07326Q36135305-70C3D723-5015-48A5-AE7B-27B5D75C554DQ36180689-79DDCA9F-F8A2-4DF1-B651-EEE2BCCA51FDQ36689169-3069ECA1-B7B3-45D3-B9BD-1930B2778796Q37356270-B3F9D58B-2A7F-405A-835A-FFEAE06C6188Q38429989-8D10135B-197F-4A1F-83BA-0F0CF571EE30Q45853348-5EE23958-3FB3-440F-995F-FC7D128D6106Q48236804-00246FAB-B29F-4843-8F2F-D9E43045DE1BQ51135004-DFA56163-D863-4C25-9BA7-14399DEF2A77Q55662343-AF3AB3D2-4393-4933-9131-5B8FF525249A
P2860
Heterogeneity of breast cancer: etiology and clinical relevance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Heterogeneity of breast cancer: etiology and clinical relevance.
@en
Heterogeneity of breast cancer: etiology and clinical relevance.
@nl
type
label
Heterogeneity of breast cancer: etiology and clinical relevance.
@en
Heterogeneity of breast cancer: etiology and clinical relevance.
@nl
prefLabel
Heterogeneity of breast cancer: etiology and clinical relevance.
@en
Heterogeneity of breast cancer: etiology and clinical relevance.
@nl
P2860
P1476
Heterogeneity of breast cancer: etiology and clinical relevance.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12094-011-0731-9
P577
2011-11-01T00:00:00Z